Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Gastroenterology and Hepatology 2, 554 (1 December 2005) | doi:10.1038/ncpgasthep0324
Improved bone mineral density with alendronate in primary biliary cirrhosis patients
Abstract
Zein CO et al. (2005) Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial. Hepatology 42: 762–771 Numerous studies have established a link between primary biliary cirrhosis (PBC) and loss of bone mass; however, a specific treatment regimen to improve bone mineral density (BMD) in such patients has yet to be established.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
